This page contains a Flash digital edition of a book.
| DERMATOLOGY | PEER-REVIEW


TREATMENT FOR ATROPHIC ACNE SCARRING


Patrick Treacy presents the results of a study investigating the efficacy of dermal fillers in the treatment of atrophic acne scarring


ABSTRACT Full title Problems encountered using dermal fillers, particularly calcium hydroxylapatite, as a treatment in acne scarring.


Objectives This article aims to establish the efficacy and safety profile of dermal fillers, especially calcium hydroxyapatite (CaHA) in the treatment of atrophic acne scars.


Methods Twenty-seven subjects with differing degrees of atrophic


A CNE


acne scarring were treated with the CaHA filler over a 12-month period. Thirteen patients were treated with low molecular weight cross-linked hyaluronic acid in a comparative study.


Results Most atrophic acne scars responded well to CaHA dermal filler treatment. Icepick scars were not treated. At 12-month evaluation, 22% of subjects showed a 75% improvement, while 48% showed a 50% improvement. This compared to an average 0% improvement for the hyaluronic acid cohort.


OCCURS IN


approximately 95% of 16–17-year-old boys and 84% of 16–17-year-old girls1


Eleven hyaluronic acid patients (85% of total) showed a 0–25% improvement in treated atrophic scars at 12 months.


Conclusions Dermal fillers, especially CaHA, can provide a safe and efficacious method of treating atrophic acne scars. This compound appears to provide a longer-lasting effect owing to volume replenishment and possible neocollagenesis. The efficacy of hyaluronic acid in repairing atrophic acne scars is not demonstrable.


DERMAL FILLER


inhibition, unhappiness, anxiety, and even suicidal thoughts as a result of their facial appearance5


. . Although the condition usually


resolves by the mid-20s, 1% of men and 5% of women still bear the signs of moderately severe acne scarring at 40 years of age2


. Some studies show


scarring of some degree may affect up to 95% of patients with acne3


. The same


study found that keloidal or hypertrophic truncal scarring were more common in men. This form of scarring is usually treated by using such measures as intralesional steroids, silicone sheeting, or vascular laser treatment. Atrophic scarring will often appear many years later, and can cause great distress in patients during their courtship years4 Affected patients report more social


.


Background For many years different treatment modalities have been used for the revision of atrophic acne scarring, with varying degrees of success. Many controlled trials have demonstrated that moderate to severe atrophic acne scars can be safely improved through ablative fractional CO2


laser


resurfacing (fractional laser skin resurfacing; FLSR)6


. Although


FLSR is still the most popular therapeutic modality for the correction of acne scars, it is not always effective in all types of atrophic lesions7


DR PATRICK TREACY is Medical Director of Ailesbury Clinics Ltd and Ailesbury Hair Clinics Ltd; Chairman of the Irish Association of Cosmetic Doctors and Irish Regional Representative of the British Association of Cosmetic Doctors; European Medical Advisor to Network Lipolysis and the UK’s largest cosmetic website Consulting Rooms. He practices cosmetic medicine in his clinics in Dublin, Cork, London and the Middle East


email: ptreacy@gmail.com Affected


patients report more social inhibition, unhappiness, anxiety, and even suicidal thoughts as a result of their facial appearance.


® the more common type of defects encountered after


KEYWORDS calcium hydroxyapatite, hyaluronic acid, acne scars, dermal fillers


prime-journal.com | March 2013





41


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140